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Abstract     
Pharmaceutical analysis is one of the most challenging fields of analytical chemistry. 
Pharmaceutical analysts carry out the qualitative and quantitative control of APIs and drug 
products and also develop and validate appropriate methods. One of my main goals was to 
develop modern, rapid, precise and reproducible, but also cost-effective HPLC assay methods 
which are generally available and applicable for most users. The aim of this work was to 
develop LC methods for both compounds. The assay of erythromycin by LC offers several 
advantages, such as high specificity, the possibility of determining and quantifying impurities 
and  degradation  products,  and  improved  accuracy.  The developed methods were 
validated. My whole work containing following plan of work as Selection of drug, Review 
Literature, FITR of both drugs and Mixture, Preparation of standard solutions, Preparation of 
sample of pure drug in Standard solution, Method development by HPLC (as Selection of 
solvents to be used as diluents and mobile phase, Selection of wavelength, Selection  of 
mobile phase and Selection of chromatographic conditions) Preparation of Mobile phase, 
Preparation of standard calibration curve combination of drug, Optimization of HPLC 
condition using box behnken design. Validation of analytical method following parameters as 
per ICH guidelines. (i). System suitability (ii). Linearity and range (iii). Specificity 
(iv).Accuracy and precision (v). Limits of detection (LOD) and Quantitation (LOQ). (vi). 
Selectivity and (vii).Robustness. 
 
  
 
Introduction 
This review article was prepared with an aim to review 
different methods developed for Azithromycin and Benzoyl 
peroxide drug by RP-HPLC analytical method and strategies 
developed and optimized for efficient method development 
[1]. There is a continuous research in this field and different 
researchers are exploiting different mobile phase combinations 
for their research work. Azithromycin which are used to treat 
various bacterial infections and Benzoyl peroxide is generally 
used to treat mild to moderate acne (Acne Vulgaris) [2-6]. 
The use of the Azithromycin and Benzoyl peroxide as a drug 
essential in pharmaceutical formulations highlights the 
requirement for its determination and quantification with 
appropriate analytical methods. This article also discusses the 
parameters that must be considered in the validation of 
analytical methods. A simple, fast, accurate and precise RP- 
HPLC method were developed and validated for  the 
estimation of Azithromycin & Benzoyl peroxide as per ICH 
guidelines. Potassium dihydrogen phosphate and Acetonitrile 
 
(50:50) are commonly used as solvents. The method was 
developed in Eclipse C18 column (Waters XTerra®, 4.6Χ250 
mm, particle 5μ) with Potassium dihydrogen phosphate and 
Acetonitrile are commonly used solvents in RP -HPLC having 
low UV cut- off of 200-400 nm respectively. 
Thus this shows that the method is capable to give a good 
detector response, the recovery calculated was within  the 
range of 98% to 101% of the specification limits. Hence the 
method was a rapid tool for routine analysis of 
Azithromycin/Benzoyl peroxide in the bulk and in the 
pharmaceutical dosage form. 
 
Analytical method development, optimization and 
validation of combination of Azithromycin and Benzoyl 
peroxide drug formulations by RP-HPLC 
Literature survey revealed that method development by 
reverse phase high performance liquid chromatographic has 
been taken for Azithromycin and Benzoyl peroxide drug 
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formulations for estimation of antibacterial & ant acne 
activity. Till now few methods have been developed for 
estimation of antibacterial & ant acne activity of drugs 
Azithromycin and Benzoyl peroxide [7-9]. Thus the aim of 
this article is to be to discuss various high performance liquid 
chromatographic methods developed by various researchers 
for determination of these antibacterial & ant acne activity 
drugs with different mobile phase combinations. This article 
also discusses the parameters that must be considered in the 
validation of analytical methods. 
Benzoyl peroxide 
Kamra et al study 
Kamra et al (2018) developed and validated Reversed-phase 
High-performance Liquid Chromatography Method for the 
Simultaneous Estimation of Benzoyl Peroxide and 
Resveratrol. 
An isocratic separation of BPO and resveratrol was achieved 
on C18, 250 mm × 4.6 mm I.d., 5 μm particle size columns 
with a flow rate of 1.2 ml/min and using a UV detector to 
monitor the elute at 245 nm. The mobile phase consisted of an 
ammonium acetate (pH 4) and ethanol. Response was a linear 
function of drug concentration in the range of 10–100 mg/mL 
range with an R2 of 0.993 for BPO and 10–100 μg/mL range 
with an R2 of 0.995 for resveratrol, accuracy with percent 
relative standard deviation of 100.65 ± 0.23 (benzoic 
peroxide) and 100.48 ± 0.45 (resveratrol) and with a limit of 
detection and quantification for BPO and resveratrol, 
respectively. The result of analysis has been validated 
statistically and by recovery study. The accuracy ranged 
between 99.65 and 101.91%. The method was found to be 
precise, reproducible, and rapid [10]. 
Jain et al study 
Jain et al (2018) developed liposomal gel of codelivery of 
benzoyl peroxide &adapalene for acne treatment. BPO-AD- 
mLipo illustrated size 256.4 ± 9.3 nm with polydispersity 
index ∼ 0.2. Significantly enhanced dermal bioavailability 
(AD-2.1, 5.4; BPO-3.0, 7.83-fold) and reduction in skin 
irritation and papule density in animal model were observed 
with BPO-AD-mLipo-gel as compared with free drugs and 
Epiduo, respectively. Hence it has been concluded that BPO- 
AD-mLipo gel provides effective and safer alternative 
approach for codelivery of anti-acne drugs [11]. 
Kawashima et al study 
Kawashima et al (2017) demonstrated Clinical efficacy and 
safety of benzoyl peroxide for acne vulgaris. Benzoyl peroxide 
(BPO) has been well established as a common medication for 
acne vulgaris in many countries (e.g. in Europe and the USA), 
where clinical data have been accumulated over a long time.  
In Japan, the use of BPO for acne treatment was approved in 
2014, and the results of clinical trials in Japanese patients have 
recently been reported. This review compares clinical study 
results between Japanese and Western patients. Clinical 
studies that had been performed in Western countries were 
searched on the basis of the criteria, double‐blind studies of 
BPO monotherapy and comparison with a vehicle group. Two 
reports of Japanese studies were also selected by using the 
same criteria. Efficacy was assessed by comparing the mean 
 
difference between the BPO and the vehicle groups for 
reduction rate in the number of lesions from baseline, and 
there were no differences between Japanese and Western 
patients. Safety assessment also showed that the incidence of 
adverse events was higher in Japanese patients than in  
Western patients, but the characteristics of the adverse events 
were not different. Therefore, we conclude that there are no 
significant differences in the efficacy and safety of BPO 
between these patient populations. The efficacy and safety of 
long‐term use in Japanese patients are also expected to be 
applicable to those in Western patients [12]. 
Sharma et al study 
Sharma et al (2016) developed Stability Indicating HPLC 
Method For Simultaneous Estimation of Clindamycin 
Phosphate and Benzoyl Peroxide In Gel Formulation. reversed 
phase High Performance Liquid Chromatographic method was 
developed for the simultaneous determination of Clindamycin 
Phosphate and Benzoyl Peroxide, using a C18 column and a 
mobile phase composed of 20 mM Ammonium acetate buffer 
pH 4.0: Methanol (45: 55 %v/v) as mobile phase at flow rate 
of 1.2 ml/min with detection wavelength of 210nm. Retention 
times in RP-HPLC method were found to be 4.49 min, 8.78 
min for Clindamycin Phosphate and Benzoyl Peroxide, 
respectively. Linearity of Clindamycin Phosphate and Benzoyl 
Peroxide were found in the range of 10.0-30.0 μg/ml and 25.0- 
75.1 μg/ml. The % recovery of Clindamycin Phosphate was 
found to be 98.45- 101.0 and 99.8- 99.38 for Benzoyl 
Peroxide. Both the drugs were subjected to acid, alkali, 
oxidation, thermal and sunlight degradation. The degradation 
products of Clindamycin Phosphate and Benzoyl Peroxide 
were well resolved from the pure drugs with significant 
differences in the retention time values [13]. 
Kim et al study 
Kim et al (2016) displayed role of combination of benzoyl 
peroxide-adeplane. The fixed-dose combination adapalene 
0.1%/benzoylperoxide 2.5% (A/BPO) was introduced as an 
acne vulgaris therapeutic in 2007. It combines anti- 
inflammatory, keratolytic, comedolytic, and antibacterial 
properties. Thus, it addresses several pathophysiological 
factors involved in the Pathophysiology of acne. This review 
highlights the rationale for the use of this fixed-dose 
combination product, its therapeutic efficacy including effects 
on adherence and quality of life, its use for different forms of 
acne, and the side-effect profile. In summary, the fixed-dose 
combination of A/BPO gel can be regarded as a highly 
effective and safe formulation. It is not associated with 
antibiotic resistance. It reduces factors that cause 
nonadherence and has positive effects on the quality of life of 
affected patients. The tolerance is good. The initial mild 
irritation potential can be addressed by adequate counseling 
[14]. 
Roy et al study 
Roy et al (2015) developed Validated Stability-Indicating RP- 
HPLC Method for the Estimation of Degradation Behaviour of 
Organic Peroxide and Third-Generation Synthetic Retinoids in 
Topical Pharmaceutical Dosage Formulation. The desired 
chromatographic separation was achieved on the Kinetex™ 
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C18 (250 × 4.6 mm, 5 µm) column using gradient elution at 
272 nm detection wavelength. The optimized mobile phase 
consisted of solvent A (mixture of 0.1% v/v glacial acetic acid 
in water and acetonitrile in the ratio of 80:20 v/v, respectively) 
and solvent B (mixture of acetonitrile: tetrahydrofuran: 
methanol in the ratio of 50:30:20 v/v/v, respectively). The 
stability-indicating capability of the developed method was 
established by analyzing forced degradation samples in which 
the spectral purity of BPO and ADP along with separation of 
all degradation products from the analyte peaks was achieved. 
The developed method was validated as per ICH guidelines 
with respect to specificity, linearity, limit of detection, limit of 
quantification, accuracy, precision, and robustness [15]. 
Ponhong et al study 
Ponhong et al (2015) developed A rapid and sensitive 
Spectrophotometric method for the determination of benzoyl 
peroxide in wheat flour samples. The detection principle is 
based on BPO reacted with 2, 20-azino-bis(3- 
ethylbenzothiazoline-6-sulfonic acid) (ABTS) to obtain a blue-
green colored product that was detected at 415 nm by 
spectrophotometry. The effect of factors influencing the color 
reaction was investigated. Under the selected conditions, the 
linear range for quantification of BPO was observed between 
0.2-10 mg/lit with r2= 0.998. The limit of detection (LOD) was 
0.025 mg/lit. The developed method obtained superior 
precision (relative standard deviation < 2%) using 11 
repeatability at 0.2 mg/lit, 0.6 mg/lit, and 0.8 mg/lit. The 
proposed methodology was successfully applied to determine 
BPO in wheat flour samples [16]. 
Hamdu et al study 
Hamdu et al (2014) developed an isocratic normal-phase high- 
performance liquid chromatographic method for the 
simultaneous determination of benzoyl peroxide and benzoic 
acid in one pharmaceutical preparation and their stability in 
different solvents. The compounds are separated on a normal 
phase column Eurospher-100, c18.4.6mmID. The mobile 
phase is methanol - water (65 + 35, v/v). Solutions are injected 
into the chromatographic system under isocratic conditions at 
a constant flow rate of 1 mL /min with UV detection at 240 
nm. Analysis of stability samples in deferent solvents showed 
formation of BPO from BA when it dissolved in ether or 
methanol and very low degradation of BPO to BA when it 
dissolved in ether compare with when it dissolved in methanol 
[17]. 
Brandstetteret et al study 
Brandstetteret et al (2011) demonstrated dose of benzoyl 
peroxide in treatment of acne. Benzoyl peroxide (BPO) is 
widely utilized in acne treatment as an alternative to 
antibiotics against which Propionibacterium acnes becomes 
more resistant. This overview examines BPO dose 
justification. Methods: Pub Med, Embase® and Science 
Citation Index searches were conducted using the keywords 
“benzoyl peroxide” and “acne vulgaris”. Limited experimental 
data are available. However, there appears no significant 
difference in the efficacy of concentrations from 2.5% to 10%. 
The extent of free fatty acids and the percutaneous penetration 
of BPO may not play a critical role in acne vulgaris [18]. 
Caldwell et al study 
Caldwell et al (1987) performed Analysis by HPLC of 
Benzoyl Peroxide Residues in Nylon Carpet Fibers. For this 
research, ANSO-IV nylon 6 staple carpet yams from Allied 
Fibers and Plastics were used. The carpet yarns were 
constructed into single bar, circular filling knit test sleeves 
which were dyed at 0.5% own with CI acid blue 25. A 
commercial acne med icationcreme containing 10% benzoyl 
peroxide was used on the fabric swatches. Two levels of 
benzoyl peroxide application were used (high and low levels). 
Both groups of samples were exposed at two levels of 
humidity and at constant temperature. Two procedures were 
used to extract BP and BA from the affected carpet tufts: a 
sonication method and a digestion method. The samples were 
analyzed by HPLC techniques developed using a gradient 
from 80% (v/v) A to 100% B in 15 minutes where A is an 
aqueous solution with pH 3 and B is acetonitrile. The results 
indicate two advantages of the HPLC method used in this 
study: a large separation of the BA peak from the void volume 
in terms of retention time, and the gradient elution allowing 
observation of both BA and BP peaks in a single 
chromatographic analysis of reasonable duration. For the 
extraction procedures, differences were noted in the results 
obtained with each of the methods [19]. 
Yong et al study 
Yong et al (1979) demonstrated use of benzoyl peroxide gel in 
treatment of acne. The results of an open clini ( al trial of200 
patients in Singapore show that benzoyl peroxide, in a 
stablvgvl formulation, both in 2.5% and 5% strengths, was 
highly efficacious in the topical treatment of acne vulgaris 
without concomitant systemic therapy. The series included a 
small number of Caucasians (13 patients) who were also 
treated effectively. Side effects noted were generally mild and 
transient [20]. 
Azithromycin 
Mokhtari et al study 
Mokhtari et al (2016) made a comparison between efficacies 
of azithromycin gel 2% with clindamycin gel 1% in patients 
with acne. Average number of papules, pustules and 
comedones was similarly reduced in both groups and, no 
significant difference was observed between the two groups (P 
> 0.05, repeated measures ANOVA). The mean indexes  of 
ASI and TLC also significantly decreased during treatment in 
both groups, no significant difference was observed between 
the two groups. (P > 0.05, repeated measures ANOVA). Also, 
impact of both drugs on papules and pustules was 2-3 times 
greater than the effect on comedones. Average satisfaction 
score was not significant between the two groups (P = 0.6, 
repeated measures ANOVA). Finally,  frequency distribution 
of complications was not significant between the two groups 
(P > 0.05, Fisher Exact test). Azithromycin gel has medical 
impact at least similar to Clindamycin Gel in treatment of mild 
to moderate acne vulgaris, and it may be consider as suitable 
drug for resistant acne to conventional topical therapy [21]. 
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Sahu et al study 
Sahu et al (2015) developed and validated reversed-phase 
HPLC method for simultaneous estimation of azithromycin in 
tablet dosage form. An isocratic, precise and accurate 
reversed-phase liquid chromatographic method was developed 
for the quantitative determination of Azithromycin in tablet 
dosage form. The separation was carried out using a mobile 
phase consisting of buffer Potassium dihydrogen Phosphate: 
Acetonitrile (HPLC grade) (pH 7.5 adjusted with ortho 
phosphoric acid). The column used was Hypersil- keystone 
C18 (250 X 4.60 mm), 5μm column with flow rate of 1.2 
ml/min using U.V. Visible detector. The detection was 
monitored at 215nm and the run time was 25min. The volume 
of injection loop was 10μl prior to injection of the drug 
solution the column was equilibrated for at least 15 min. The 
retention times of Azithromycin were found to be 9.761. 
Results of analysis were validated statistically and by recovery 
studies. Forced degradation method is used for detection of 
degraded impurities in body fluids shows better results than 
reported. The results of the study conclude that the proposed 
RP-HPLC method is a simple, specific, definite, precise, and 
less time consuming method which is useful for the routine 
determination of Azithromycin in its pharmaceutical dosage 
form [22]. 
Ghari et al study 
Ghari et al (2014) developed azithromycin encapsulated 
nanoparticles by using response surface methodology. AZI- 
loaded poly (DL-lactide-co-glycolide) (PLGA) nanoparticles 
were prepared using the nanoprecipitation method and 
characterized. The Box-Behnken design (BBD) was employed 
to optimize the effects of different variables on particle size 
and drug encapsulation efficiency of nanoparticles. The results 
of optimized formulations showed a polydispersity index of 
0.06 %, an average diameter of 183 ± 1.8 nm, and the 
encapsulation efficiency of 57.83 ± 4.8 %. The prepared 
particles had the spherical shape, and the in vitro drug release 
profile showed a biphasic pattern, showing an initial burst 
release of 23 % in the first 2 h followed by a sustained release 
for up to 24 h. [23]. 
Ghari et al study 
Ghari et al (2013) developed a Simple RP-HPLC-UV Method 
for Determination of Azithromycin in Bulk and 
Pharmaceutical Dosage forms as an Alternative to the USP 
Method. The best stationary phase was determined as C18 
column, 5 μm; 250 mm × 4.6 mm. Mobile phase was  
optimized to obtain a fast and selective separation of the drug. 
Flow rate was 1.5 mL/min, Wavelength was set at 210 nm and 
the volume of each injection was 500 μL. An isocratic 
methanol/buffer mobile phase at the ratio of 90:10 v/v  gave 
the best separation and resolution. The proposed method was 
accurate, precise, sensitive, and linear over a wide range of 
concentration of azithromycin. The developed method has the 
advantage of using UV detector compared to the USP method 
in which electrochemical detector has been used.  The 
validated method was successfully applied to the 
determination of azithromycin in bulk and pharmaceutical 
dosage forms [24]. 
Sudheer et al study 
Sudheer et al (2012) a sensitive and specific isocratic RP- 
HPLC was developed for quantitative estimation of 
Azithromycin and AmbroxolHCl tablet formulation. The 
developed method consisting the mobile phase K2HPO4 – pH 
6.5 : (68 : 32) with isocratic programming, Hypersil, BDS, C 
8, column (150 mm x 4.6 mm i.d., 5μm particle size) as 
stationary phase with a flow rate of 1.5 mL/minute by using 
max 215nm and PDA detector. Proposed method was found to 
be linear in the concentration range of 100.0 to 360.0 μg/mL 
for Azithromycin and 15.0 to 54.0μg/mL for 
AmbroxolHClrespectively, the correlation coefficient was 
found to be 0.999. Precision study showed that the percentage 
relative standard deviation was within the range of acceptable 
limits, and the mean recovery was found to be 100.36 % for 
Azithromycin and 100.24% for AmbroxolHCl. The developed 
method was validated for specificity by stress studies. 
AmbroxolHCl and Azithromycin were subjected to stress 
condition and products were analyzed by using photo diode 
array detector. It was found to be stable in milder condition of 
stress (0.1 M HCl, 0.1 M NaOH, 3% H2O2, at 60°C/10 
minutes). The analyte peaks were well resolved from the 
degraded impurities [25]. 
Al-Rimawi et al study 
Al-Rimawi et al (2010) developed a method of HPLC analysis 
of azithromycin and its related compounds. Liquid 
chromatography with a UV detector at a wavelength of 210  
nm using a reversed-phase C(18) stationary phase has been 
employed in this study. Isocratic elution is employed using a 
mixture of phosphate buffer-methanol (20:80). This new 
method is validated in accordance with USP requirements for 
new methods for assay determination, which include accuracy, 
precision, specificity, linearity, and range. This method shows 
enough selectivity, sensitivity, accuracy, precision, and 
linearity range to satisfy Federal Drug Administration and 
International Conference of Harmonization regulatory 
requirements. The current method demonstrates good linearity 
over the range of 0.3-2.0 mg/mL of azithromycin. The 
accuracy of the method is 100.5% with a relative standard 
deviation of 0.2%. The precision of this method reflected by 
relative standard deviation of replicates is 0.2%. The method  
is sensitive with a detection limit of 0.0005 mg/mL for 
azithromycin. Impurities and degradation products of 
azithromycin can be selectively determined with a good 
resolution in both raw material and pharmaceutical forms [26]. 
Senthil Raja et al study 
SenthilRaja et al (2010) A simple reverse phase liquid 
chromatographic method has been developed and 
subsequently validated for simultaneous determination of 
Azithromycin and Ambroxol Hydrochloride in combined 
dosage form. The separation was carried out using a mobile 
phase consisting of acetonitrile and mono basic potassium 
phosphate buffer of pH 8.5 in the ratio of 65:35 v/v. The 
column used was C18 phenomenex Gemini 5m, 250cm x 
4.6mm id with flow rate of 2ml/min using PDA detection at 
220nm. The described method was linear over a concentration 
range of 96-145mg/ml and 80- 125mg/ml for the assay of 
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Azithromycin and Ambroxol Hydrochloride respectively. The 
retention times of Ambroxol and Azithromycin were found to 
be 3.7min and 6.1min respectively. Results of analysis were 
validated statistically and by recovery studies. The limit of 
quantification (LOQ) for Azithromycin and Ambroxol 
Hydrochloride were found to be 96.7mg/ml and 8.35mg/ml 
respectively. Then the limit of detection (LOD) for 
Azithromycin and Ambroxol Hydrochloride were found to be 
31.91 mg/ml and 2.75 mg/ml respectively [27]. 
Nájlaet et al study 
Nájlaet et al (2010) the objective of this research was to 
develop and validate an alternative analytical method for 
quantitative determination of Levofloxacin in tablets and 
injection preparations. The calibration curves were linear over 
a concentration range from 3.0 to 8.0 μg mL-1. The relative 
standard deviation was below 1.0% for both formulations and 
average recovery was 101.42 ± 0.45% and 100.34 ± 0.85% for 
tablets and injection formulations, respectively. The limit of 
detection and limit of quantitation were 0.08 and 0.25 μg mL- 
1, respectively. It was concluded that the developed method is 
suitable for the quality control of Levofloxacin in 
pharmaceuticals formulations [28]. 
Singh et al study 
Singh et al (2010) A RP-HPLC method was developed and 
validated for quantitative determination of azithromycin in 
pharmaceutical suspension dosage forms.  The 
chromatography was carried out on a Phenomenex C  18 (150 
x 4.6 mm i.d., 5μ) column with Acetonitrile: 0.5  % Formic 
acid as mobile phase (Isocratic A: B = 40: 60 % v/v), at 215 
nm detector wave length with a flow rate of 1 ml/min. 
Clarithromycin was used as an internal standard. The linearity 
was established in the range of 20 - 600 ng/ml for HPLC. The 
HPLC method was accurate and precised for azithromycin 
suspension with a recovery of 98.75 to 99.44%. The spiked 
sample solutions were stable upto 1 month. This validated 
method can be used for estimation of azithromycin in 
pharmaceutical suspension [29]. 
Shizarpour et al study 
Shizarpour et al (2008) deiplayed comparison between 
Topical Azithromycin and Clindamycin in the Treatment of 
Mild to Moderate Acne Vulgaris. Dermatologists are in 
agreement about topical treatment in the mild to moderate 
acne vulgaris, but extensive using of tropical antibiotics and 
drug resistance have decreased their therapeutic benefits. In 
this study, we tried to compare the therapeutic effects of 
tropical azithromycin and clindamycin. This study was 
designed and performed as a double blind, randomized clinical 
trial. Thirty two patients with mild to moderate acne were 
treated with azithromycin and 30 patients, who were matched 
with the former group based on age, sex and severity of the 
disease, were treated with clindamycin for 12 weeks and 
results of their treatment were compared with each other. 
Results of this study showed that ratio of response to treatment 
and decreasing the grade of the disease and number of 
nodules, papules and pustules were not significantly different 
in the first month of the treatment in both groups while just the 
number of nodules in the group on azithromycin showed more 
decrease in the last months of treatment in comparison with 
clindamycin (0.88±0.75 vs. 0.25±0.75, p=0.015). Also, 
clindamycin had more side effects, but the rate of satisfaction 
with both drugs were high and showed no difference. In this 
study, no significant association was found between sex and 
response to treatment and evaluation of association between 
age and response to treatment showed a significant reverse 
association between age and decreasing the number  of 
pustules [30]. 
Bardazzi et al study 
Bardazzi et al (2007) demonstrated role of azithromycin in 
acne treatment on adolescents. A majority of patients (47/52) 
showed remarkable improvement in the first 4 weeks with a 
more than 20 percent reduction of their inflammatory papulo- 
pustular lesions. Maximum clearance was observed in 32 
patients at 8 weeks. Slow improvement with eruptions of new 
lesions was seen in 6 patients. Adverse events, such as 
heartburn and nausea, were reported by 3 patients. All patients 
completed the 8-week study period. The beneficial effect was 
maintained at 4 months after the conclusion of treatment. 
Therefore it has been concluded that Azithromycin, 500 mg 
thrice weekly for 8 weeks, appears to be a safe and effective 
treatment for acne vulgaris in adolescents, with excellent 
patient compliance [31]. 
Ghoshal et al study 
Ghoshal et al (2007) performed Comparative evaluation of 
effectiveness of adapalene and azithromycin, alone or in 
combination, in acne vulgaris. Acne vulgaris, a disorder of the 
pilosebaceous structure, is a common disorder in adolescents 
and young adults that is associated with significant morbidity. 
The aim of this study was to compare the effects of the drugs 
adapalene and azithromycin, given separately and in 
combination in acne vulgaris. Methodology: A total of 61 
newly attending cases of inflammatory acne vulgaris were 
considered the study. They were randomly allocated into three 
groups. Group 1 received topical adapalene (0.01%) gel, group 
2 received oral azithromycin, whereas group 3 was given a 
combination of these two. The patients were treated for a 
period of 12 weeks, being reviewed every fortnightly. The 
results obtained were analyzed in detail using statistical 
methods. The combination of adapalene and azithromycin 
caused the highest reduction in the inflamed lesion count 
followed by azithromycin given singly. Further, monotherapy 
with adapalene was used. However, this difference in efficacy 
was small and not statistically significant (P = 0.717). 
Azithromycin lead to a rapid reduction in the inflammatory 
lesion count, but it had negligible action on noninflamed 
lesions. At the end of 12 weeks of treatment, the three 
treatment groups showed no statistically significant difference 
in the efficacy in inflammatory acne [32]. 
Suhagia et al study 
Suhagia et al (2006) a simple and sensitive 
Spectrophotometric method has been developed for 
determination of azithromycin in its pharmaceutical dosage 
forms. In the proposed method, azithromycin is oxidized with 
potassium permanganate to liberate formaldehyde, which is 
determined in situ using acetyl acetone, in the presence of 
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ammonium acetate. A yellow colouredchromogen was 
obtained, having an absorption maximum at 412 nm. The 
method is found to be linear in the concentration range of 10- 
75μg/ml, with regression coefficient of 0.9978. Various 
reaction parameters such as concentration of potassium 
permanganate and reagent, time required for oxidation, and 
maximum colour intensity were optimized. The method was 
validated, and can be used successfully to assay azithromycin 
in its pharmaceutical dosage forms viz. tablets, capsules, and 
injections [33]. 
Kulikov et al study 
Kulikov et al (2004) developed and validated Micellar Liquid 
Chromatographic Method with UV Detection for 
Determination of Azithromycin in Tablets and Capsules. A 
rapid and simple micellar liquid chromatographic method that 
does not require use of specific chromatographic columns has 
been developed and validated for azithromycin determination. 
The method uses a Hypersil C18 column at 60 °C, 1-butanol– 
pH 6.86 phosphate buffer solution–water, 15:25:60 (v/v), 
containing 0.10 M sodium dodecyl sulfate, as mobile phase, 
and UV-detection at 215 nm. Different characteristics of the 
method were validated satisfactorily. The specificity, 
accuracy, linearity, precision (repeatability), and robustness of 
the method were demonstrated. The method proved suitable 
for determination of the azithromycin content of capsules and 
uncoated tablets [34]. 
Kamau et al study 
Kamau et al (2002), developed Isocratic Liquid 
Chromatographic Method for the Analysis of Azithromycin 
and Its Structurally Related Substances in Bulk Samples. AZT 
is separated from its synthesis intermediates and a degradation 
product as well as from six unknown impurities on an XTerra 
RP18 column at 70°C using a mobile phase consisting of 
acetonitrile–pH 6.5 0.2M K2HPO4–water (35:10:55, v/v/v) at 
1.0 mL/min. The XTerrastationary phase contains methyl 
groups that are incorporated in the bulk structure of the 
material. This allows for special selectivities. Robustness is 
evaluated by a full factorial design experiment. The method 
shows good selectivity, repeatability, linearity, and sensitivity 
[35]. 
Zubata et al study 
Zubata et al (2001) developed a new HPLC method for 
azithromycin quantitation. A simple liquid chromatographic 
method was developed for the estimation of azithromycin raw 
material and in pharmaceutical forms. The sample was 
chromatographed on a reverse phase C18 column and eluants 
monitored at a wavelength of 215 nm. The method was 
accurate, precise and sufficiently selective. It is applicable for 
its quantitation, stability and dissolution test [36]. 
Combination in treatment of Acne 
Akter et al study 
Akter et al (2018) performed a clinical trial study of Oral 
Azithromycin Pulse Therapy and Daily Topical Benzoyl 
Peroxide in the Treatment of Acne Vulgaris. It was an open, 
controlled, clinical trial, conducted on 37 out patients with 
acne vulgaris. Patients were clinically assessed at baseline &at 
week 0,4, 8 and 12. Evaluation included success rate (subjects 
clear or excellent improvement, good response), lesion count 
& percentage change in lesion count from baseline, cutaneous 
tolerability & adverse events. The combination of oral 
azithromycin pulse therapy & daily topical benzoyl peroxide 
was very safe & effective with significant differences in 
percentage of lesion count change observed as early as 1-4 
weeks. Adverse events were more frequent with the 
combination therapy that occurred early in the study &were 
transient. This study revealed that combination regimen of 
azithromycin &benzoyl peroxide (4%) is indeed very much 
efficacious & safe in the management of acne vulgaris [37]. 
Sardana et al study 
Sardana et al (2016) performed a cross-sectional pilot study of 
antibiotic resistance in Propionibacterium acnes strains in 
Indian acne patients using 16s-RNA polymerase chain 
reaction: A comparison among treatment modalities including 
antibiotics, benzoyl peroxide, and isotretinoin. The follicular 
content was sampled and the culture was verified with 16S 
rRNA polymerase chain reaction, genomic sequencing, and 
pulsed-field gel electrophoresis. Minimum inhibitory 
concentration (MIC) assessment was done for erythromycin 
(ERY), azithromycin (AZI), clindamycin (CL), tetracycline 
(TET), doxycycline (DOX), minocycline (MINO), and 
Levofloxacin (LEVO). The four groups of patients were 
compared for any difference in the resistant strains. Results: 
Of the 52 P. acnes strains isolated (80 patients), high 
resistance was observed to AZI (100%), ERY (98%), CL 
(90.4%), DOX (44.2%), and TETs (30.8%). Low resistance 
was observed to MINO (1.9%) and LEVO (9.6%). Statistical 
difference was seen in the resistance between CL and TETs; 
DOX/LEVO and DOX/MINO (P < 0.001). High MIC90 
(≥256 μg/ml) was seen with CL, macrolides, and TETs; 
moreover, low MIC90 was observed to DOX (16 μg/ml), 
MINO (8 μg/ml), and LEVO (4 μg/ml). Though the treatment 
group with isotretinoin/BPO had the least number of resistant 
strains there was no statistical difference in the antibiotic 
resistance among the various groups of patients. Conclusions: 
High resistance was seen among the P. acnes strains to 
macrolides-lincosamides (AZI and CL) while MINO and 
LEVO resistance was low [38-39]. 
Central composite design for RP HPLC 
Siregar et al study 
Siregar et al (2017), central composite design (CCD) was used 
for optimization of high performance liquid chromatographic 
(HPLC) method for simultaneous analysis of curcumin (CUR) 
and demethoxycurcumin (DMC) in tablets containing 
Curcuma extract. Separation of CUR and DMC was  
performed using X-Bridge C18 column (250 x 4.6 mm i.d; 5 
μm). Four factors that were investigated include the 
concentration of acetic acid (X1), ratio of acetic acid (X2), 
flow rate of mobile phase (X3) and column temperature (X4). 
Based on responses obtained (retention time, peak area, 
resolution and tailing factor), the optimum condition selected 
was X1 = 3.00%, X2 = 51%, X3 = 1.05 mL/min and X4 = 
45oC. This HPLC condition was validated by  assessing 
several validation parameters including system suitability test, 
selectivity,   linearity,   precision,   accuracy   and   robustness 
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according to International Conference Harmonization (ICH). 
All validation parameters meet the acceptance criteria set by 
ICH. The validated method was successfully used for analysis 
of CUR and DMC in tablets containing Curcuma extract. CCD 
was effective means in optimization of HPLC for analysis of 
CUR and DMC in pharmaceutical formulation [40]. 
Fatma et al study 
Fatma et al (2017) performed Central composite design and 
response surface methodology for the optimization of Ag+- 
HPLC/ELSD method for triglyceride profiling. The study 
presents the application of central composite design (CCD) 
and response surface methodology (RSM) for the optimization 
of silver-ion normal phase HPLC/ELSD (Ag+-HPLC/ELSD) 
method parameters to profile the isomers of triglycerides in 
vegetable oils. The significance of a second-order polynomial 
model for predicting the optimal values of Ag+-HPLC/ELSD 
method parameters was evaluated by the analysis of variance, 
ANOVA, and 3D response surface plots for the interactions 
between three variables were constructed. Three experimental 
parameters were chosen as independent variables which are 
the flow rate of mobile phase, temperature of column 
compartment and concentration of sample. A multivariate five-
level CCD and RSM were used to confirm a quadratic model 
as a functional relationship between the response values (Rs, 
N, α and k′) and variables. The optimum values of parameters 
were found to be a flow rate of 1.25 mL min−1, temperature of 
column compartment of 20 °C, and sample concentration of 
5 × 10−2 mg µL−1. Regression analysis with an R2 values 
indicated as an adequate correlation between the experimental 
and predicted response values. ANOVA test results were also 
confirm that the models can be successfully used to predict the 
optimum parameters of Ag+-HPLC/ELSD method. Therefore, 
the proposed model provides an efficient, automated, and 
robust Ag+-HPLC/ELSD method for triglyceride profiling and 
is also suitable for a number of applications and analytical 
method developments for  vegetable oils [41]. 
 
Kalariya et al study 
Kalariya et al (2017) applied experimental design and 
response surface technique for selecting the optimum RP- 
HPLC conditions for the determination of moxifloxacinHCl 
and ketorolac tromethaminein eye drops. A method has been 
developed for the separation of moxifloxacin HCl and 
ketorolac tromethamineusing reverse phase high-performance 
liquid chromatography (RP-HPLC) on C18 column (250 · 4.6 
mm, 5 lm) with UV detection at 308  nm.  Experimental 
designs were applied for multivariate optimization of the 
experimental conditions of RP-HPLC method. Three 
independent factors: methanol content in the mobile phase 
composition, buffer pH and flow rate were used to design 
mathematical models. Here faced central composite (FCC) 
experimental design was used to study the response surface 
technique and to study in depth the effects of these 
independent factors. Derringer’s desirability function was 
applied to simultaneously optimize the retention time of last 
eluting peak (ketorolac tromethamine) and tailing factor of 
moxifloxacin. The predicted optimum assay condition 
consisted of methanol and potassium dihydrogen phosphate 
buffer (pH 3.2; 25 mM, 0.5% Triethylamine) in  a proportion 
of 60:40% v/v, respectively, as the mobile phase at a flow rate 
of 1.2 mL min1. Using this optimum condition, baseline 
separation of both drugs with good resolution and a run time  
of less than 7 min were achieved. The optimized assay 
condition was validated according to ICH guidelines to 
confirm specificity, linearity, accuracy and precision [42]. 
Ayoub et al study 
Ayoub et al (2016) utilized experimental design in 
chromatographic method development. A guide experimental 
design in chromatographic method development was  
described and applied successfully to the analysis of different 
recently approved anti-diabetic pharmaceutical combinations. 
Enhancement of UHPLC analysis of alogliptin benzoate either 
with pioglitazone hydrochloride or with metformin 
hydrochloride was achieved. The optimal chromatographic 
conditions were not attained by trial and error that requires a 
large number of experiments. Alternatively, a computer 
program was used as a systematic optimization strategy for the 
design of the experiment which accurately predicts the 
combined effect of different factors simultaneously. 
Resolution between peaks was studied by the proposed 
fractional factorial design approach performed by the 
Minitab® Program using screening and optimization steps. 
Application of the central composite design was implemented. 
A Pareto chart was used to exclude the insignificant variables. 
Linearity ranges were found to be 0.5-40 μg ml-1, 1-20 μg ml- 
1 and 1-32 μg ml-1 for alogliptin benzoate, pioglitazone 
hydrochloride and metformin hydrochloride, respectively. The 
proposed method is applicable for the analysis of six 
pharmaceutical dosage forms namely, Nesina®, Actos®, 
Glucophage®, Oseni®, Kazano® and Actoplus MET® tablets 
[43]. 
Bapatu et al study 
Bapatu et al (2016) applied QbD Approach Method 
Development for Estimation of Dabigatran Etexilate along 
with Its Impurities and Identification of Degradants in Capsule 
Dosage Form. Method design, method evaluation, method 
control and life cycle management were explained by 
systematic flow chart. Analytical Target Product profile was 
defined. The method was developed using the Inertsil ODS- 
3V, 150 mm × 4.6 mm, 5 μm column using the gradient 
program with ammonium formate buffer as mobile phase A 
and acetonitrile as mobile phase B. Risk assessment was 
performed as part of method evaluation. Design of experiment 
tools was used to optimize the chromatographic conditions. A 
two-level Full Factorial Design along with Face Centered 
Central Composite design augmentation was employed and 
statistical analysis of the experimental data uncovered the 
significant influential of chromatographic factors. The design 
space and the contour plot suggest that the current center point 
parameters can be further modified, resulting in better 
acceptability of the response parameters. The performance of 
the optimized method was validated according to current ICH 
guidelines. Dabigatran Etexilate Capsules was subjected to 
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various stress conditions like oxidative, acid, base, hydrolytic, 
thermal, humidity, and photolytic degradations and evaluated 
chromatograms at 220 nm. The degradation products  were 
well separated from each other and main peak, demonstrating 
the stability-indicating power of the method. One of the major 
degradants impurities, which are forming in neutral hydrolysis 
stress condition, is isolated and characterized by using 
analytical techniques like IR, LC-MS and NMR. Degradation 
pathway for Dabigatran Etexilate was proposed based on 
forced degradation data along with reaction mechanism [44]. 
Shakyaya et al study 
Shakyaya  et   al   (2016)  developed  and   validated  Stability- 
Indicating Liquid Chromatographic Method for Determination 
of Valsartan and Hydrochlorothiazide Using Quality by 
Design. Optimized mobile phase (v/v/v) was water (containing 
0.25 ml/L triethylamine), methanol and acetonitrile (50:38:37, 
pH adjusted to 3.0±0.1). Chromatographic separation was 
achieved on Hypersil®-Gold C18 (150 x 4.6 mm, 5 μm, 
Thermo Fisher Scientific, USA), column at 25 ± 2 °C. The 
method was validated as per the “International Conference on 
Harmonisation” (ICH) guidelines. Chromatographic run time 
was 10.0 minutes. The linearity range for valsartan and 
hydrochlorothiazide were 1.25-64.00 μg/ml and 0.195-10.00 
μg/ml respectively. The limits of detection (LOD)  for 
valsartan and hydrochlorothiazide were 0.253 and 0.0226 
μg/ml  while the limits  of quantitations (LOQ)  were 0.767 and 
0.068 μg/ml respectively, using 10μl sample. Stability studies 
indicate that the degradation of valsartan was higher during 
oxidative stress than other stress conditions [45]. 
Uysal et al study 
Uysal et al (2016) performed Optimization of RPLC Method 
for Separation of Some Acetylcholinesterase Inhibitors by 
using Central Composite Design. Method development, 
acetonitrile concentration, pH of mobile phase and column 
temperature were investigated using central composite design 
(CCD). Afterwards, the optimal conditions were found 
employing central composite design and Derringer's 
desirability function. Effect of these variables on the output 
responses such as retention factors, resolutions (Rs) and 
retention time (tR) were evaluated. The separation was applied 
by using X Terra C18 column (250 × 4.6 mm ID, 5 µm). The 
optimum assay conditions were: acetonitrile-water binary 
mixture (45:55, v/v) and pH 9.5 as the mobile phase and at 
column temperature 33°C. Total chromatographic  analysis 
time per sample was approximately 12.5 min. The method 
showed good agreement between the experimental data and 
predictive value throughout the studied parameter space. By 
using equations obtained CCD, protonation constant values 
(pKa) of donepezil, galantamine and rivastigmine were also 
predicted [46]. 
Sathiyasundar et al study 
Sathiyasundar et al (2015) optimized liquid chromatographic 
method for the simultaneous separation and estimation of 
zaltoprofen and paracetamol in human plasma sample. The 
new drug combination of zaltoprofen and paracetamol are 
widely used as analgesic and antiinfilamatery medication. 
There is no method reported for simultaneous estimation of 
this combination for plasma samples. On considering these 
facts a new reliable, sensitive and accurate reverse phase 
liquid chromatographic method has been developed for 
simultaneous quantitative estimation of these drugs in human 
plasma sample using probinicid as internal standard. In the 
preliminary screening steps, a factorial design was employed 
to identify the factors that had significant effects on the 
selected chromatographic responses. Based on this responses 
analyses time (tR3), Capacity factor (k1) and selectivity (α) 
was optimized using Rotatable Central Composite Design 
(RCCD) and Response Surface Methodology (RSM). Further, 
this optimized condition was used to analyze the spiked  
plasma samples, reconstituted by a plasma protein 
precipitation method. The sample was efficiently separated 
using Reverse Phase Liquid Chromatography method 
equipped with PDA detector. The chromatographic separation 
was carried out using supelcosil LC-8 (150mm × 4.6mm I.D 
and 5μm particle size) analytical column measured at 254 nm. 
The developed RP-HPLC method can be applied for the 
estimation of quantitative pharmacokinetics in preclinical and 
clinical studies [47]. 
Chen et al study 
Chen et al (2015) optimized and validated High-Performance 
Chromatographic Condition for Simultaneous Determination 
of Adapalene and Benzoyl Peroxide by Response Surface 
Methodology. An optimized mobile phase composed of 
acetonitrile, tetrahydrofuran and water containing 0.1% acetic 
acid at a ratio of 25:50:25 by volume was successfully 
predicted by using RSM. An isocratic separation was achieved 
by using the condition. Furthermore, the analytical  method 
was validated in terms of specificity, linearity, accuracy and 
precision in a range of 80% to 120% of the expected 
concentration. Finally, the method was successfully applied to 
the analysis of a commercial product [48]. 
Singh et al study 
Singh et al (2014) optimized RP-HPLC method for 
Investigation of Emtricitabine Loaded Poly(lactic-co-glycolic 
acid) Nanoparticles. NPs were evaluated for in vitro release 
and in vivo absorption study. The desired chromatographic 
separation was achieved on a Phenomenex C18 (250mm × 
4.6mm I.D., 5 𝜇m) column, under isocratic conditions using 
UV detection at 280 nm. The optimized mobile  phase 
consisted of a mixture of 40mM phosphate dihydrogen 
phosphate buffer (pH 6.8), methanol, and 2% acetonitrile in a 
ratio of (83 : 15 : 2, v/v/v) at a flow rate of 1 mL/min. The 
linear regression analysis for the calibration curves showed a 
good linear correlation over the concentration range 0.040–2.0 
𝜇g/mL, with retention time of 4.39 min. An average 
encapsulation efficiency of 74.34% was obtained for NPs. In 
vitro studies showed zero-order release and about 95% drug 
being released within 15 days in PBS (pH 7.4). In conclusion, 
the proposed optimized method was successfully applied for 
the determination of in vitro and in vivo release studies of 
emtricitabine NPs [49]. 
XIN et al study 
XIN et al (2014) Optimized HPLC Condition of Ursolic Acid 
and Oleanolic Acid by Central Composite Design. Effects of 
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HPLC mobile phase and column on the separation and 
determination of ursolic acid and oleanolic acid were in 
vestigated. By using the resolution and the analysis time as 
response values, the main influencing factors of HPLC(the 
volumetric ratio of methanol and aqueous phase in the mobile 
phase, the volume fraction of phosphoric acid in the aqueous 
phase, as well as the flow rate of the mobile phase and the 
column temperature) were optimized by central composite 
design. An effective and fast method for the separation and 
determination of ursolic acid and oleanolic acid by HPLC was 
established. The results showed that oleanolic acid and ursolic 
acid were effectively separated within 23 min with the 
resolution of 1.739, when the chromatographic separation was 
performed on a Shim-pack ODS-CLC (M) column kept at 
21℃, using the methanol and aqueous phase containing 0.05% 
phosphoric acid with the volumetric ratio of 91.7:8.3 as the 
mobile phase at a flow rate of 0.6 mL/min, and the detection 
wavelength was set at 210 nm [50]. 
Khodadoust et al study 
Khodadoust et al (2013) optimized HPLC UV method of 
dispersive liquid–liquid micro extraction with central 
composite design for preconcentration of chlordiazepoxide 
drug. A simple, rapid, and sensitive method based on 
dispersive liquid–liquid micro extraction combined with 
HPLC‐UV detection applied for the quantification of 
chlordiazepoxide in some real samples. The effect of different 
extraction conditions on the extraction efficiency of the 
chlordiazepoxide drug was investigated and optimized using 
central composite design as a conventional efficient tool. 
Optimum extraction condition values of variables were set as 
210 μL chloroform, 1.8 mL methanol, 1.0 min extraction time, 
5.0 min centrifugation at 5000 rpm min−1, neutral pH, 7.0% 
w/v NaCl. The separation was reached in less than 8.0 min 
using a C18 column using isocratic binary mobile phase 
(acetonitrile/water (60:40, v/v)) with flow rate of 1.0 mL 
min−1. The linear response (r2 > 0.998) was achieved in the 
range of 0.005–10 μg mL−1 with detection limit 0.0005 μg 
mL−1. The applicability of this method for simultaneous 
extraction and determination of chlordiazepoxide in four 
different matrices (water, urine, plasma, and chlordiazepoxide 
tablet) were investigated using standard addition method. 
Average recoveries at two spiking levels were over the range 
of 91.3–102.5% with RSD < 5.0% (n = 3). The obtained 
results show that dispersive liquid–liquid micro extraction 
combined with HPLC‐UV is a fast and simple method for the 
determination of chlordiazepoxide in real samples [51]. 
Petkovska et al study 
Petkovska et al (2008) applied experimental design approach 
for the development and validation of an enantiospecificrp- 
hplc method for simultaneous determination of clopidogreland 
related compounds. Experimental design was applied during 
the method optimization (Full factorial 23 design) and 
robustness testing (Central Composite Face Centered design). 
Laboratory mixtures of clopidogrel and its impurities in a 
concentration ratio of 1: 5.0×10–4 were used as an 
investigation matrix. The three independent variables were the 
acetonitrile content in the mobile phase, pH of the mobile 
phase, and the column temperature. A Chromatographic 
Response Function (CRF) was used for estimation of the 
system response resolution (Rs). Separation was achieved 
using mobile phase composition  of ACN: Buffer  solution  pH 
6.5 (40:60 v/v) at 30oC. A CHIRAL-AGP 4.0 mm × 100 mm, 
5.0 μm particle size column was used. The total time for 
chromatographic separation was approximately 10.0 min. The 
method was validated for its selectivity, linearity, precision, 
accuracy and robustness [52]. 
Conclusion 
It was concluded that the proposed new RP-HPLC method 
developed for the quantitative determination of Azithromycin 
and Benzoyl peroxide in bulk was simple, selective, sensitive, 
accurate, precise and rapid. The method was proved to be 
superior to most of the reported methods. The mobile phases 
were simple to prepare and economical. In this method, 
correlation coefficient was found to be 0.998 for Benzoyl 
peroxide and 0.997 for Azithromycin. 
The method was found to be accurate, precise, repeatable and 
reproducible with different instruments and analysts. Limit of 
quantification ion for Benzoyl peroxide and for Azithromycin 
0.044μg/ml and 0.02μg/ml respectively. Similarly limit of 
detection or Benzoyl peroxide and for Azithromycin 
0.015μg/ml and 0.009μg/ml respectively. 
So, simple, sensitive, accurate, precise RP- HPLC methods 
were developed and validated for the simultaneous estimation 
of Benzoyl peroxide and Azithromycin. 
The method also finds use in clinical, biological and 
pharmacokinetic studies for the drug Azithromycin and 
Benzoyl peroxide. The method was validated as per ICH 
guidelines, and validation acceptance criteria were met in all 
cases. Hence, this method was specific,  stability-indicating 
and can be successfully used for the estimation of drug in bulk 
and pharmaceutical dosage forms. 
 
References 
1. Xiong Y, Xiao KP, Rustum AM. Development and 
validation of a stability-indicating RP-HPLC method to 
separate low levels of dexamethasone and other related 
compoundsfrom betamethasone. J Pharmaceut Biomed Anal, 
2009;49: 646-654. 
2. Zmuida, China. "How to Give a Child Azithromycin". 
Retrieved 2013-01-06. 
3. Adolfo C. Fernandez-Obregon, MD, Azithromycin for the 
treatment of acne, International Journal of Dermatology 
2000;39: 45–50. 
4. Tilelli, John A.; Smith, Kathleen M.; Pettignano, Robert. 
"Life-Threatening Bradyarrhythmia After Massive 
Azithromycin Overdose". Pharmacotherapy 2006;26(1): 147–
50. 
5. Baselt, R. (2008). Disposition of Toxic Drugs and Chemicals 
in Man (8th ed.). Foster City, CA: Biomedical Publications. 
pp. 132–133. 
6. Azithromycin Side Effects". WebMD. Retrieved 28 March 
2015. 
7. Cartwright, Hugh (17 March 2005). "Chemical Safety Data: 
Benzoyl peroxide". Oxford University. Retrieved 13 August 
2011. 
Singh et al. / Indian J. Pharm. Biol. Res.,2018; 6(2):53-63 
Review Article 62 
 
 
 
8. "Skin tumor-promoting activity of benzoyl peroxide, a... 
[Science. 1981] - PubMed - NCBI". 
9. Leyden, James J.; Kligman, Albert M, "Contact sensitization 
to benzoyl peroxide", Contact Dermatitis 3 1977;(5): 273– 
75. 
10. [10]. Manju Kamra, Anupama Diwan, Satish Sardana, 
Development and Validation of Reversed-phase High- 
performance Liquid Chromatography Method for the 
Simultaneous Estimation of Benzoyl Peroxide and 
Resveratrol, International Journal of Pharmaceutical & 
Biological Archives 2018; 9(2):113-121. 
11. Jain S1, Kale DP1, Swami R1, Katiyar SS, Codelivery of 
benzoyl peroxide & adapalene using modified liposomal gel 
for improved acne therapy, Nanomedicine (Lond). 
2018;13(12):1481-1493 
12. Makoto Kawashima, Toshitaka Nagare, and Masaharu, 
Clinical efficacy and safety of benzoyl peroxide for acne 
vulgaris: Comparison between Japanese and Western 
patients, J Dermatol. 2017; 44(11): 1212–1218. 
13. Madhuri Sharma, Ankita Bhavsar, A.Ramkishan, Stability 
Indicating HPLC Method For Simultaneous Estimation of 
Clindamycin Phosphate and Benzoyl Peroxide In Gel 
Formulation, Am. J. PharmTech Res. 2016; 6(2);632-640. 
14. Su Youn Kim and Falk R Ochsendorf, New developments in 
acne treatment: role of combination adapalene– 
benzoylperoxide, Ther Clin Risk Manag. 2016; 12: 1497– 
1506. 
15. Chinmoy Roy, Lalatendu Panigrahi, and Jitamanyu 
Chakrabarty, Validated Stability-Indicating RP-HPLC 
Method for the Estimation of Degradation Behaviour of 
Organic Peroxide and Third-Generation Synthetic Retinoids 
in Topical Pharmaceutical Dosage Formulation, Sci Pharm. 
2015; 83(2): 321–338. 
16. Kraingkrai Ponhong , Sam-ang Supharoek, Watsaka 
Siriangkhawut, Kate Grudpan, A rapid and sensitive 
Spectrophotometric method for the determination of benzoyl 
peroxide in wheat flour samples, journal of food and drug 
analysis 2015;23:652 -659. 
17. Hazim Hamid Hamdu, An isocratic normal-phase high- 
performance liquid chromatographic method for the 
simultaneous determination of benzoyl peroxide and benzoic 
acid in one pharmaceutical preparation and their stability in 
different solvents, IOSR Journal of Pharmacy and Biological 
Sciences (IOSR-JPBS) 2014;9(1): 04-12. 
18. Andreas J. Brandstetter, Howard I. Maibach, Topical dose 
justification: benzoyl peroxide concentrations, Journal of 
Dermatological Treatment 2013;24(4): 275-7. 
19.  J. Caldwell, T. Perenich, Recovery and Analysis by HPLC 
of Benzoyl Peroxide Residues in Nylon Carpet Fibers, 
Textile Research Journal 1987, 1. 
20. Chuah Chong Yong, Benzoyl Peroxide Gel Therapy In Acne 
In Singapore, Intfknational Journal Of Dermatology,july- 
August 1979;18: 486-490. 
21. Fatemeh Mokhtari, Gita Faghihi, Akram Basiri, Sadaf 
Farhadi, Mohammadali Nilforoushzadeh, and Shadi Behfar1, 
Comparison effect of azithromycin gel 2% with clindamycin 
gel 1% in patients with acne, Adv Biomed Res. 2016; 5: 72. 
22. Adarsh Sahu, Mahendra Prasad Jatavb, Reetesh Vinodec and 
Kamal Yadavd, Development and validation of a reversed- 
phase HPLC method for simultaneous estimation of 
azithromycin in tablet dosage form, IJPC 2015; 05:09. 
23. T.Ghari, S.A.Mortazavi M.R.Khoshay, F.Kobarfard, 
K.Gilani, Preparation, optimization, and in vitro evaluation 
of azithromycin encapsulated nanoparticles by using 
response surface methodology, Journal of Drug Delivery 
Science and Technology 2014;24(4): 352-360. 
24. Tayebeh Ghari, Farzad Kobarfard, Seyed Alireza 
Mortazavia, Development of a Simple RP-HPLC-UV 
Method for Determination of Azithromycin in Bulk and 
Pharmaceutical Dosage forms as an Alternative to the USP 
Method, Iran J Pharm Res. 2013; 12(Suppl): 57–63. 
25. M. Sudheer1, A. B. N. Nageswara Rao, D. Hari Hara Theja, 
M. Siva Prakash, P. Ramalingam1 and A. Madhan Mohan, 
Development of Stability Indicating RPHPLC Method for 
Simultaneous Determination of Azithromycin and 
AmbroxolHCl (SR) in the Tablet Formulation; Scholars 
Research LibraryDer Pharmacia Lettre, 2012; 4 (3):803-810. 
26. Al-Rimawi F, Kharoaf M., Analysis of azithromycin and its 
related compounds by RP-HPLC with UV detection, J 
Chromatogram Sci. 2010 Feb;48(2):86-90. 
27. M. Senthil Raja1, Shan. S.Ha., P. Perumala., and M.T.S. 
Moorthy, RP-HPLC Method development and validation for 
the simultaneous estimation of Azithromycin and ambroxol 
hydrochloride in tablets; International Journal of PharmTech 
Research;2010;2(1);36-39. 
28. Nájla Mohamad Kassab, Marcos Serrou do Amaral; Anil 
Kumar Singh; Maria Inês Rocha Miritello SantoroIII, 
Development and validation of UV Spectrophotometric 
method for determination of levofloxacin in pharmaceutical 
dosage forms,Quim. Nova, 2010;33(4);4-37. 
29. Sachin Kumar Singh, Dev Prakash, Tamizh Mani T, 
Development and Validation of Stability indicating RP- 
HPLC Method for the estimation of Azithromycin 
Suspension; International Journal of Chem Tech 
Research;2010;2(4);1939-44. 
30. Mohammad Shizarpour, Alireza Firooz, Hamidreza Pazooki, 
Samad Rezai Khiabanloo, Comparison of Topical 
Azithromycin and Clindamycin in the Treatment of Mild to 
Moderate Acne Vulgaris, Iranian Journal of Dermatology, 
2008; 11(2): 67-72. 
31. Bardazzi F1, Savoia F, Parente G, Tabanelli M, Balestri R, 
Spadola G, Dika E, Azithromycin: a new therapeutical 
strategy for acne in adolescents, Dermatol Online J. 2007 Oct 
13;13(4):4. 
32. Loknath Ghoshal, Sabyasachi Banerjee, Sadhan Kumar 
Ghosh, Dwijendra Nath Gangopadhyay, Sukumar Jana, 
Comparative evaluation of effectiveness of adapalene and 
azithromycin, alone or in combination, in acne vulgaris, 
2007;52(4): 179-183. 
33. BN Suhagia, SA Shah, IS Rathod, HM Patel, KR 
Doshi,Determination of Azithromycin in pharmaceutical 
dosage forms by Spectrophotometric method,IJPS;2006; 68( 
2); 242-245. 
34. A.U. KulikovEmail authorA. G. Verushkin, Development  
and Validation of a Micellar Liquid Chromatographic 
Method with UV Detection for Determination of 
Azithromycin in Tablets and Capsules, Chromatographia 
July 2004;60(1-2): 33–38. 
35. F.N. Kamau, H.K. Chepkwony, J.K. Ngugi, D. 
Debremaeker, E. Roets, and J. Hoogmartens, Isocratic Liquid 
Chromatographic Method for the Analysis of Azithromycin 
Singh et al. / Indian J. Pharm. Biol. Res.,2018; 6(2):53-63 
Review Article 63 
 
 
 
and Its Structurally Related Substances in Bulk Samples, 
Journal of Chromatographic Science, 2002;40: 529-533. 
36. Patricia Zubata, Rita Ceresole, Maria Ana Rosasco, Maria 
Teresa Pizzorno, A new HPLC method for azithromycin 
quantitation, Journal of Pharmaceutical and Biomedical 
Analysis 2002;27:833–836. 
37. Bilqis Akter, Oral Azithromycin Pulse Therapy and Daily 
Topical Benzoyl Peroxide in the Treatment of Acne 
Vulgaris: An Open Clinical Trial Study, Journal of 
Bangladesh College of Physicians and Surgeons, 2018;36 (1 
):11-15. 
38. Kabir Sardana, Tanvi Gupta, Bipul Kumar, Hemant K 
Gautam, Vijay K Garg, A cross-sectional pilot study of 
antibiotic resistance in Propionibacterium acnes strains in 
Indian acne patients using 16s-RNA polymerase chain 
reaction: A comparison among treatment modalities 
including antibiotics, benzoyl peroxide, and isotretinoin, 
Indian journal of dermatology,2016;61(1):45-52. 
39. Semwal A, Ramandeep S. Preparation, characterization and 
biological evaluation of chitosanmoxifloxacin prodrugs for 
pharmaceuticals. Marmara Pharm. J 2014; 18(1): 036-042. 
40.  Chairany Siregar, Niken K. Prabaningdyah, Syaiful Choiri, 
Sugeng Riyanto and Abdul Rohman, Optimization of HPLC 
Using Central Composite Design for Determination of 
Curcumin and Demethoxycurcumin in Tablet Dosage Form, 
Dhaka Univ. J. Pharm. Sci. 2017;16(2): 137-145. 
41. Fatma Nur ArslanEmail authorHuseyin Kara, Central 
composite design and response surface methodology for the 
optimization of Ag+-HPLC/ELSD method for triglyceride 
profiling, Journal of Food Measurement and Characterization 
June 2017; 11(2): 902–912. 
42. Pradipbhai D. Kalariya, Deepak Namdev, R. Srinivas, S. 
Gananadhamu a, Application of experimental design and 
response surface technique for selecting the optimum RP- 
HPLC conditions for the determination of moxifloxacin HCl 
and ketorolac tromethamine in eye drops. Journal of Saudi 
Chemical Society 2017; 21: S373–S382. 
43. B. M. Ayoub, O. ABDEL-AZIZ, A guide for using 
experimental design in chromatographic method 
development: applied to the analysis of selected anti-diabetic 
pharmaceutical combinations. Pharmazie 2016;71:683-687. 
44. Hanimi Reddy Bapatu1, Ravi Kumar Maram, Woo Hyung 
Cho, Venkat Bhaskar Rao Pasagadugula,, QbD Approach 
Method Development for Estimation of Dabigatran Etexilate 
along with Its Impurities and Identification of Degradants in 
Capsule Dosage Form, AJAC2016;7(6):494-524. 
45. [45]. Asho k K. SHakyaya, Development and Validation of a 
Stability-Indicating Liquid Chromatographic Method for 
Determination of Valsartan and Hydrochlorothiazide Using 
Quality by Design, Orient. J. Chem., 2016; 32(2): 777-788. 
46. Ramazan Uysal, Yaşar Doğan Daldal, Zehra Üstün, Ebru 
Çubuk Demiralay, Optimization of RPLC Method for 
Separation of Some Acetylcholinesterase Inhibitors by using 
Central Composite Design, Eurasian J Anal Chem 2016;( Sp 
1):23–43. 
47. R. Sathiyasundar, P. Venkatesan, M. Swamivelmanickam, R. 
Suresh, K. Valliappan and K. Kannan, Multicriteria 
optimization of an liquid chromatographic method for the 
simultaneous separation and estimation of zaltoprofen and 
paracetamol in human plasma sample: Application of 
chemometric protocols. Der Pharmacia Lettre, 2015; 7 
(10):262-269. 
48. Yi-Cheng Chen, Pi-Ju Tsai, Yaw-Bin Huang, 1 and Pao-Chu 
Wu , Optimization and Validation of High-Performance 
Chromatographic Condition for Simultaneous Determination 
of Adapalene and Benzoyl Peroxide by Response Surface 
Methodology, PLoS One. 2015; 10(3): e0120171. 
49. Gurinder Singh and Roopa S. Pai, Optimization (Central 
Composite Design) and Validation of HPLC Method for 
Investigation of Emtricitabine Loaded Poly(lactic-co- 
glycolic acid) Nanoparticles: In Vitro Drug Release and In 
Vivo Pharmacokinetic Studies, The Scientific World Journal, 
2014;1-12. Article ID 583090, 12 pages 
http://dx.doi.org/10.1155/2014/583090 
50. XING Ya-li, BI Liang-wu, ZHAO Zhen-dong, HAN Lu-lu, 
XIA Tian-juan, Optimization of the HPLC Condition of 
Ursolic Acid and Oleanolic Acid by Central Composite 
Design, Chemistry and Industry of Forest Products 2014; 
22(4): 37-41. 
51. Saeid Khodadoust Mehrorang Ghaedi, Optimization of 
dispersive liquid–liquid micro extraction with central 
composite design for preconcentration of chlordiazepoxide 
drug and its determination by HPLC‐UV, Journal of 
separation science, 2013;36(11): 1734-1742. 
52. Rumenka Petkovska1, Claus Cornett2, Aneta Dimitrovska, 
experimental design approach for the development And 
validation of an enantiospecific rp-hplc method For 
simultaneous determination of clopidogrel And related 
compounds, Macedonian Journal of Chemistry and Chemical 
Engineering, 2008;27(1):53–64. 
 
 
 
 
All © 2018 are reserved by Indian Journal of Pharmaceutical and Biological Research 
 
This Journal is licensed under a Creative Commons Attribution-Non Commercial -Share Alike 3.0 Unported License. This article can be downloaded to 
ANDROID OS based mobile. 
Cite this article Narendra Singh*, Yogenra Singh, R.S.Bhadauria & Jeyabalan Govindasamy. A review on analytical method 
development, optimization and validation of combination of Azithromycin and benzoyl peroxide by RP-HPLC using design of 
experiment as per ICH guideline. Indian J. Pharm. Biol. Res.2018; 6(2):53-63. 
